Hospitals are investing heavily in rhythm management technologies, yet many providers still struggle to expand access to advanced cardiac care. The growing conversation around atrial fibrillation (Afib) market restraints reveals a deeper challenge that goes beyond treatment demand and enters the territory of affordability, infrastructure, and clinical readiness.
As healthcare systems race to...